The analysis of gene regulatory networks and oncogenic pathway activities revealed significantly higher GSVA scores for PI3K-AKT-MTOR and MTORC1 signaling in SClow HNSCC. This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.